EBV variant | NPC | Healthy subjects | OR | 95% CI | P value |
---|---|---|---|---|---|
Data_GD1 | |||||
 155391G | 28 | 132 | 1 |  |  |
 G155391A | 10 | 40 | 1.53 | 0.66–3.54 | 0.321 |
 155391A | 119 | 147 | 4.47 | 2.71–7.37 | <0.001 |
 P †trend |  |  |  |  | <0.001 |
Data_GD2 | |||||
 155391G | 28 | 125 | 1 |  |  |
 G155391A | 2 | 5 | 1.98 | 0.35–11.33 | 0.443 |
 155391A | 138 | 111 | 5.20 | 3.18–8.50 | <0.001 |
 P †trend |  |  |  |  | <0.001 |
Data_GD3 | |||||
 155391G | 99 | 357 | 1 |  |  |
 G155391A | 12 | 84 | 0.61 | 0.32–1.17 | 0.136 |
 155391A | 615 | 439 | 5.27 | 4.06–6.85 | <0.001 |
 P †trend |  |  |  |  | <0.001 |
Data_SD | |||||
 155391G | 40 | 560 | 1 |  |  |
 G155391A | 0 | 18 | 0 | 0-Inf | 0.987 |
 155391A | 18 | 34 | 7.52 | 3.69–15.32 | <0.001 |
 P †trend |  |  |  |  | <0.001 |
Overalla | |||||
 155391G | 195 | 1174 | 1 |  |  |
 G155391A | 24 | 147 | 0.92 | 0.56–1.51 | 0.746 |
 155391A | 890 | 731 | 5.27 | 4.31–6.44 | <0.001 |
 P †trend |  |  |  |  | <0.001 |
 I 2 |  |  | 0 |  |  |
 P ‡ |  |  |  |  | 0.710 |